Appeal No. 95-0371
Application 07/965,304
rheumatoid arthritis as Carrera suggests 2-chloro-deoxyadenosine is. If so, the examiner
should issue an appropriate office action which sets forth such a rejection. We would
again urge the examiner to use the model for obviousness rejections set forth in MPEP
706.02(j).
REVERSED-IN-PART, VACATED-IN-PART, REMANDED
SHERMAN D. WINTERS )
Administrative Patent Judge )
)
)
WILLIAM F. SMITH ) BOARD OF PATENT
Administrative Patent Judge ) APPEALS AND
) INTERFERENCES
)
FRED E. McKELVEY )
Administrative Patent Judge )
10
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: November 3, 2007